Document:

Exhibit 10.136

EXHIBIT B(1)

 

WARRANT TO PURCHASE STOCK

 

Company: VG Life Sciences Inc.

Number of Shares: 200,000

Class of Stock: Common

Initial Exercise Price Per Share: $0.63

Issue Date: September 16, 2014

 

 

 THIS WARRANT CERTIFIES THAT, for good and valuable consideration,
DW Odell Company, LLC, a California limited liability company (“Holder”) is entitled to purchase the number of fully
paid and nonassessable shares of the class of securities (the “Shares”) of VG Life Sciences Inc. (the “Company”
or “VGLS”) at the initial exercise price per Share (the “Warrant Price”) all as set forth above and as
adjusted pursuant to Article 2 of this Warrant, subject to the provisions and upon the terms and conditions set forth of this
Warrant.

 

ARTICLE 1. EXERCISE

 

 1.1     Method of Exercise. Holder
may exercise this Warrant by delivering a duly executed Notice of Exercise in substantially the form attached as Appendix 1 to
the principal office of the Company. Unless Holder is exercising the conversion right set forth in Section 1.2, Holders shall also
deliver to the Company a check for the aggregate Warrant Price for the Shares being purchased.

 

1.2     Conversion Right. In lieu
of exercising this Warrant as specified in Section 1.1, Holder may from time to time convert this Warrant, in whole or in part,
into a number of Shares determined by dividing (a) the aggregate fair market value of the Shares or other securities otherwise
issuable upon exercise of this Warrant minus the aggregate Warrant Price of such Shares by (b) the fair market value of one Share.
The fair market value of the Shares shall be determined pursuant Section 1.4.

 

1.3     No Rights Shareholder. This
Warrant does not entitle Holder to any voting rights as a shareholder of the Company prior to the exercise hereof.

 

1.4     Fair Market Value. For purposes
of Section 1.2, if the Shares are traded in a public market, the fair market value of the Shares shall be the closing price of
the Shares (or the closing price of the Company’s stock into which the Shares are convertible) reported for the business
day immediately before Holder delivers its Notice of Exercise to the Company. If the Shares are not traded in a public market,
the Board of Directors of the Company shall determine fair market value in its reasonable good faith judgment. The foregoing notwithstanding,
if Holder advises the Board of Directors in writing that Holder disagrees with such determination, then the Company and Holder
shall promptly agree upon a reputable investment banking or public accounting firm to undertake such valuation. If the valuation
of such investment banking firm is greater than that determined by the Board of Directors, then all fees and expenses of such investment
banking firm shall be paid by the Company. In all other circumstances, such fees and expenses shall be paid by Holder.

 

    	 

    	 

    

1.5     Delivery of Certificate and New
Warrant. Promptly after Holder exercises or converts this Warrant, the Company shall deliver to Holder certificates for the
Shares acquired and, if this Warrant has not been fully exercised or converted and has not been fully exercised or converted and
has not expired, a new Warrant representing the Shares not so acquired.

 

1.6     Replacement of Warrants.
On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and,
in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to
the Company or, in the case of mutilation, or surrender and cancellation of this Warrant, the Company at its expense shall execute
and deliver, in lieu of this Warrant, a new warrant of like tenor.

 

1.7     Repurchase on Sale, Merger, or
Consolidation of the Company

 

1.7.1     “Acquisition” 
For the purpose of this Warrant, “Acquisition” means (a) the closing of the sale, transfer or other disposition of
all or substantially all of the VGLS’s assets, (b) the consummation of the merger or consolidation of VGLS with or into another
entity (except a merger or consolidation in which the holders of capital stock of VGLS immediately prior to such merger or consolidation
continue to hold at least fifty percent (50%) of the voting power of the capital stock of VGLS or the surviving or acquiring entity),
or any transaction or series of transactions to which VGLS is a party in which in excess of fifty percent (50%) of VGLS’s
voting power is transferred, or (c) the exclusive license of all or substantially all of the intellectual property of VGLS to a
third party.

 

1.7.2     Assumption of Warrant.
Upon the closing of any Acquisition the successor entity shall assume the obligations of this Warrant, and this Warrant shall be
exercisable for the same securities, cash, and property as would be payable for the Shares issuable upon exercise of the unexercised
portion of this Warrant as if such Shares were outstanding on the record date for the Acquisition and subsequent closing.

 

1.7.3     Purchase Right. At the
election of Holder, the Company shall purchase the unexercised portion of this Warrant for cash upon the closing of any Acquisition
for an amount equal to (a) the fair market value of any consideration that would have been received by Holder in consideration
of the Shares had Holder exercised the unexercised portion of this Warrant immediately before the record date for determining the
shareholders entitled to participate in the proceeds of the Acquisition, less (b) the aggregate Warrant Price of the Shares, but
in no event less than zero.

 

ARTICLE 2. ADJUSTMENTS TO THE SHARES.

 

2.1     Stock Dividends, Splits, Etc.
If the Company declares or pays a dividend on its common stock ( or the Shares if the Shares are securities other than common stock
) payable in common stock, or other securities, subdivides the outstanding common stock into a greater amount of common stock,
or, if the Shares are securities other than common stock, subdivides the Shares in a transaction that increases the amount of common
stock into which the Shares are convertible, then upon exercise of this Warrant, for each Share acquired, Holder shall receive,
without cost to Holder, the total number and kind of securities to which Holder would have been entitled had Holder owned the Shares
of record as of the date the dividend or subdivision occurred.

    	 

    	 

    

 

2.2     Reclassification, Exchange or
Substitution. Upon any reclassification, exchange, substitution, or other event that results in a change of the number and/or
class of the securities issuable upon exercise or conversion of this Warrant, Holder shall be entitled to receive, upon exercise
or conversion of this Warrant, the number and kind of securities and property that Holder would have received for the shares if
this Warrant had been exercised immediately before such reclassification, exchange, substitution, or other event. Such an event
shall include any automatic conversion of the outstanding or issuable securities of the Company of the same class or series as
the Shares to common stock pursuant to the terms of the Company’s Certificate of Incorporation upon the closing of a registered
public offering of the Company’s common stock. The Company or its successor shall promptly issue to Holder a new Warrant
for such new securities or other property. The new adjustments provided for in this Article 2 including, without limitation, adjustments
to the Warrant Price and to the number of securities or property issuable upon exercise of the new Warrant. The provisions of this
Section 2.2 shall similarly apply to successive reclassifications, exchanges, substitutions, or other events.

 

2.3     Adjustments for Combinations,
Etc. If the outstanding Shares are combined or consolidated, by reclassification or otherwise, into a lesser number of shares,
the Warrant price shall be proportionately increased.

 

2.4     Adjustments for Diluting Issuances.
The number of shares of common stock issuable upon conversion of the Shares, shall be subject to adjustment, from time to time
in the manner set forth in the Company’s Certificate of Incorporation with respect to issuance of securities for a price
lower than certain prices specified in the Certificate of Incorporation.

 

2.5     No Impairment. The Company
shall not, by amendment of its Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger,
dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms to be observed or performed under this Warrant by the Company, but shall at all times in good faith assist in
carrying out of all the provisions of this Article 2 and in taking all such action as may be necessary or appropriate to protect
Holder’s rights under this Article against impairment. If the Company takes any action affecting the Shares or its common
stock other than as described above that adversely affects Holder’s rights under this Warrant, the Warrant Price shall be
adjusted downward and the number of Shares issuable upon exercise of this Warrant shall be adjusted upward in such a manner that
the aggregate Warrant price of this Warrant is unchanged.

 

2.6     Fractional Shares.  No fractional
Shares shall be issuable upon exercise or conversion of the Warrant and the number of Shares to be issued shall be rounded down
to the nearest whole Share. If a fractional share interest arises upon any exercise or conversion of the Warrant, the Company shall
eliminate such fractional share interest by paying Holder amount computed by multiplying the fractional interest by the fair market
value of a full Share.

 

    	 

    	 

    

 

2.7     Certificate as to Adjustments.
Upon each adjustment of the Warrant Price, the Company at its expense shall promptly compute such adjustment, and furnish Holder
with a certificate of its Chief Financial Officer setting forth such adjustment and the facts upon which such adjustment is based.
The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant price in effect upon the date thereof
and the series of adjustments leading to such Warrant Price.

 

ARTICLE 3. REPRESENTATIONS AND COVENANTS
OF THE COMPANY.

 

3.1     Representations and Warranties.
The Company hereby represents and warrants to the Holder that all Shares which may be issued upon the exercise of the purchase
right represented by this Warrant and all securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be
duly authorized, validly issued, fully paid and nonassessable, and free of any liens and encumbrances except for restrictions on
transfer provided for herein or under applicable federal and state securities laws.

 

3.2      Notice of Certain Events.
If the Company proposes at any time (a) to declare any dividend or distribution upon its common stock, whether in cash, property,
stock or other securities and whether or not a regular cash dividend; (b) to offer for subscription pro rata to the holders of
any class or series or other rights; (c) to effect any reclassification or recapitalization of common stock; (d) to merge or consolidate
with or into any other corporation, or sell, lease, license, or convey all or substantially all of its assets, or to liquidate,
dissolve or wind up; or (e) offer holders of registration rights the opportunity to participate in an underwritten public offering
of the Company’s securities for cash, then, in connection with each such event, the Company shall give Holder (1) at least
20 days prior written notice of the date on which a record will be taken for such dividend, distribution or subscription rights
(and specifying the date on which the holders of common stock will be entitled thereto) or for determining rights to vote, if any,
in respect of the matters referred to in (c) and (d) above; 2 in the case of the matters referred to in (c) and (d) above at least
20 days prior written notice of the date when the same will take place (and specifying the date on which the holders of common
stock will be entitled to exchange their common stock for securities or other property deliverable upon the occurrence of such
event); and (3) in the case of the matter referred to in (e) above, the same notice as is given to the holders of such registration
rights.

 

3.3     Information Rights. So long
as the Holder holds this Warrant and /or any of the Shares, the Company shall deliver to the Holder (a) promptly after mailing,
copies of all notices or other written communications to the shareholders of the Company, (b) within ninety (90) days after the
end of each fiscal year of the Company, the annual financial statements of the Company.

 

3.4     Registration Under Securities
Act of 1933, as amended.  The Company agrees that the Shares shall be subject to the registration rights granted to any other
holders of the Company’s common stock.

 

    	 

    	 

    

 

ARTICLE 4. MISCELLANEOUS.

 

4.1     Term. This Warrant is exercisable,
in whole or in part, at any time and from time to time on or after the fourth anniversary of the Issue Date hereof and up to and
including the fifth anniversary of the Issue Date.

 

4.2     Legends.  This Warrant and
the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) shall be imprinted with
a legend in substantially the following form:

 

THIS SECURITY HAS NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION
THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS
COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.

 

4.3     Compliance with Securities Laws
on Transfer. This Warrant and the Shares issuable upon exercise this Warrant (and the securities issuable, directly or indirectly,
upon conversion of the shares, if any) may not be transferred or assigned in whole or in part without compliance with limitation,
the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company, as reasonable requested
by the Company). The Company shall not require Holder to provide an opinion of counsel if the transfer is to an affiliate of Holder
or if there is no material question as to the availability of current information as referenced in rule 144(c), Holder represents
that it has complied with Rule 144(d) and (e) in reasonable detail, the selling broker represents that it has complied with Rule
144(f), and the Company is provided with a copy of Holder’s notice of proposed sale.

 

4.4     Transfer Procedure.Subject
to the provisions of Section 4.2, Holder may transfer all or part of this Warrant or the Shares issuable upon exercise of this
Warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) by giving the Company notice
of the portion of the Warrant being transferred setting forth the name, address and taxpayer identification number of the transferee
and surrendering this Warrant to the Company for reissuance to the transferee(s) (and Holder if applicable).

 

4.5     Notices. All notices and
other communications from the Company to the Holder, or vice versa, shall be deemed delivered and effective when given personally
or mailed by first-class registered or certified mail, postage prepaid, at such address as may have been furnished to the Company
or the Holder, as the case may be, in writing by the Company or such Holder from time to time.

 

4.6     Waiver. This Warrant and
any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which
enforcement of such change, waiver, discharge or termination is sought.

 

    	 

    	 

    

 

4.7     Attorneys Fees. In the event
of any dispute between the parties concerning the terms and provisions of this Warrant , the party prevailing in such dispute shall
be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorney’s fees.

 

4.8     Governing Law.  This Warrant
shall be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles
regarding conflicts of law.

 

 

 

	 	 	 
	 	 	By: Haig Keledjian
	 	 	Title: Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 

    	 

    

 

APPENDIX 1

 

 

NOTICE OF EXERCISE

 

 

 

1.    The undersigned hereby elects to
convert the attached Warrant into in the manner specified in the Warrant. This conversion is exercised with respect to _______________________
of the Shares covered by the Warrant.

 

 

 

2.     Please issue a certificate or certificates
representing said shares in the name of the undersigned or in such other name as is specified below:

 ________________________________________

(Name)

 

 ________________________________________

 

 ________________________________________ 

(Address)

 

3.    
The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for any other party
and not with a view toward the resale or distribution thereof except in compliance with applicable securities laws.

 

 

 

	 	 	 
		 	 
	(Date)	 	(Signature)Exhibit 10.137

 

EXHIBIT A(1)

 

VG LIFE SCIENCES INC.

CONVERTIBLE PROMISSORY NOTE

 

THIS CONVERTIBLE PROMISSORY
NOTE (“Note”) is issued as of September 16, 2014 (the “Original Issue Date”), by VG Life Sciences Inc.,
a Delaware corporation (the “Company”), in an aggregate principal amount of $50,000.00.

 

Terms not otherwise
defined herein shall have the meanings given in Section 6 below.

 

FOR VALUE
RECEIVED, the Company promises to pay to Wild Harp Holdings, LLC, or registered assigns (the “Holder”), the
principal sum of fifty thousand dollars ($50,000.00), on or before July 9, 2016 (the “Maturity Date”) and to pay
simple interest to the Holder on the principal sum, at the rate per annum of eight percent (8%). Interest shall accrue daily
commencing on the Original Issue Date until payment in full of the principal sum, together with all accrued and unpaid
interest, has been made or duly provided for. Interest shall be calculated on the basis of a 360-day year. Interest hereunder
will be due and payable at the Maturity Date, to the person in whose name this Note is registered on the records of the
Company (the “Note Register”). The principal of, and interest on, this Note are payable in such coin or currency
of the United States of America as at the time of payment is legal tender for payment of public and private debts, at the
address of the Holder last appearing on the Note Register. A transfer of the right to receive principal and interest under
this Note shall be transferable only through an appropriate entry in the Note Register as provided herein.

 

This Note is subject
to the following additional provisions:

 

Section 1. Convertible
Note and Warrant Purchase Agreement. This Note is one of the Notes issued pursuant to that certain Convertible Note and Warrant
Purchase Agreement (the “Agreement”) between the Company and Holder dated as of July 9, 2014. This Note is subject
to, and qualified by, all the terms and conditions set forth in the Agreement.

 

Section 2.Events
of Default.

 

Section 2.1Events
of Default Defined; Acceleration of Maturity. If an Event of Default (as defined in the Agreement) has occurred then upon
the occurrence of any such Event of Default, the Holder may, by notice to the Company, declare the unpaid principal amount of
the Notes to be, and the same shall forthwith become, due and payable, without presentment, demand, protest or other notice of
any kind, all of which are hereby waived by the Company, together with the interest accrued thereon and all other amounts payable
by the Company hereunder and pursue all of Holder’s rights and remedies hereunder and under the other Loan Documents and
all other remedies available to Holder under applicable law.

 

 

    	1

    	 

    

 

Section 3.Optional
Conversion.

 

(a)The outstanding
principal and all accrued and unpaid interest of this Note shall be convertible, at the option of the Holder, into shares of common
stock of the Company (“Common Stock”) at the Conversion Ratio, at the option of the Holder, in four equal tranches
(25% each) on the following dates: October 9, 2015, January 9, 2016, April 9, 2016, and July 9, 2016. Any conversion under this
Section 3(a) shall be of a minimum amount of U.S. $5,000 of Notes. The Holder shall effect conversions by surrendering
the Notes (or such portions thereof) to be converted to the Company, together with the form of conversion notice attached hereto
as Exhibit A (the “Conversion Notice”) in the manner set forth in Section 3(h). Each Conversion Notice
shall specify the principal amount of Notes to be converted and the date on which such conversion is to be effected (the “Conversion
Date”). Subject to Section 3(b), each Conversion Notice, once given, shall be irrevocable. If the Holder is converting
less than all of the principal amount represented by the Note(s) tendered by the Holder with the Conversion Notice, the Company
shall promptly deliver to the Holder a new Note for such principal amount as has not been converted.

 

(b)Not later than
fifteen (15) Business Days after the Conversion Date, the Company will deliver to the Holder (i) a certificate or certificates
containing the restrictive legends and trading restrictions required by law, if any, representing the number of shares of Common
Stock being acquired upon the conversion of Notes and (ii) Notes in principal amount equal to the principal amount of Notes not
converted; provided, however that the Company shall not be obligated to issue certificates evidencing the shares of Common
Stock issuable upon conversion of any Notes, until Notes are either delivered for conversion to the Company or any transfer Holder
for the Notes or Common Stock, or the Holder notifies the Company that such Notes have been lost, stolen or destroyed and provides
a lost instrument indemnity to the Company to indemnify the Company from any loss incurred by it in connection therewith. If such
certificate or certificates are not delivered by the date required under this Section 3(b), the Holder shall be entitled
by written notice to the Company at any time on or before its receipt of such certificate or certificates thereafter, to rescind
such conversion, in which event the Company shall immediately return the Notes tendered for conversion.

 

(c)(i)The conversion
price (“Conversion Price”) for each Note in effect on any Conversion Date shall be $0.084, which is equal to 10% less
than the lowest consecutive 3 day average closing price during the period beginning July 15, 2014 and ending September 15, 2014,
subject to adjustment as otherwise contemplated by this Section 3(c).

 

(ii)In case of any Acquisition (as defined below)
of the Company, then Holder shall have the right thereafter to convert any principal and interest remaining owing under this Note
prior to the closing of any such Acquisition. At the election of Holder, Holder may convert this Note into the shares of stock
and other securities and property receivable upon or deemed to be held by holders of Common Stock following such Acquisition,
and the Holder shall be entitled upon such event to receive such amount of securities or property as the shares of the Common
Stock, into which the Note could have been converted immediately prior to such Acquisition, would have been entitled. The terms
of any such Acquisition shall include such terms so as to continue to give to the Holder the right to receive the securities or
property set forth in this Section 3(c) upon any conversion following such Acquisition. This provision shall similarly
apply to successive Acquisitions. “Acquisition” means (a) the closing of the sale, transfer or other disposition of
all or substantially all of the VGLS’s assets, (b) the consummation of the merger or consolidation of VGLS with or into
another entity (except a merger or consolidation in which the holders of capital stock of VGLS immediately prior to such merger
or consolidation continue to hold at least fifty percent (50%) of the voting power of the capital stock of VGLS or the surviving
or acquiring entity), or any transaction or series of transactions to which VGLS is a party in which in excess of fifty percent
(50%) of VGLS’s voting power is transferred, or (c) the exclusive license of all or substantially all of the intellectual
property of VGLS to a third party

 

    	2

    	 

    

 

 

(iii)The
Conversion Price shall be subject to adjustment as follows:

 

(A)In
case the Company shall (i) pay a dividend in shares of its capital stock, (ii) subdivide its outstanding shares of Common Stock,
(iii) combine its outstanding shares of Common Stock into a smaller number of shares, or (iv) issue by reclassification of its
shares of Common Stock any shares of the Company, the Conversion Price in effect immediately prior thereto shall be adjusted so
that the Holder of this Note thereafter surrendered for conversion shall be entitled to received the number of shares of Common
Stock which he would have owned or have been entitled to receive after the happening of any of the events described above, had
this Note been converted immediately prior to the happening of such event. Such adjustment shall be made whenever any of the events
listed above shall occur. An adjustment made pursuant to this subdivision (A) shall become effective retroactively immediately
after the record date in the case of a dividend and shall become effective immediately after the effective date in the case of
a subdivision, combination or reclassification.

 

(B)
If, at any time while this Note is outstanding, the Company takes any voluntary action or any event occurs as to which the
foregoing subdivisions are not strictly applicable, but the failure to make an adjustment in the Conversion Price hereunder would
not fairly protect the rights, without dilution, represented by this Note, then the Conversion Price in effect immediately prior
thereto shall be adjusted so that the Holder of this Note shall be entitled to receive the number of shares of Common Stock which
he would have owned or been entitled to receive after the happening of any such action or event, had this Note been converted
immediately prior to the happening of any such action or event.

 

(d)The
Company covenants that it will at all times reserve and keep available out of its authorized and unissued Common Stock solely
for the purpose of issuance upon conversion of Notes as herein provided, free from preemptive rights or any other actual contingent
purchase rights of persons other than the holders of Notes, such number of shares of Common Stock as shall be issuable upon the
conversion of the aggregate principal amount of all outstanding Notes. The Company covenants that all shares of Common Stock that
shall be so issuable shall, upon issue, be duly and validly authorized, issued and fully paid and nonassessable.

 

(e)
Upon a conversion hereunder the Company shall not be required to issue stock certificates representing fractions of shares
of Common Stock, but may, if otherwise permitted, make a cash payment in respect of any final fraction of a share based on the
Conversion Price at such time.

 

    	3

    	 

    

 

 

(f)The
issuance of certificates for shares of Common Stock on conversion of Notes shall be made without charge to the Holder for any
documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificate, provided that
the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery
of any such certificate upon conversion in a name other than that of the Holder and the Company shall not be required to issue
or deliver such certificates unless or until the person or persons requesting the issuance thereof shall have paid to the Company
the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid.

 

(g)Notes
converted into Common Stock shall be canceled.

 

(h)Each
Conversion Notice shall be given by email or mail, postage prepaid, addressed to the Controller of the Company of VG Life Sciences
Inc. located 121 Gray Avenue, Suite 200, Santa Barbara, CA 93101. Any such notice shall be deemed given and effective upon the
earliest to occur of (i) receipt of such email at the email address specified in this Section 3(h), (ii) five days after
deposit in the United States mails or (iii) upon actual receipt by the party to whom such notice is required to be given.

 

Section
4.Mandatory Conversion.

 

(a)In
the event Holder has not elected to convert all of the principal and interest remaining owing under this Note on or prior to two
years after the date of this note, the then outstanding principal and accrued and unpaid interest amount of this Note shall, without
further action by the Holder or the Company, be automatically converted in whole into that number of shares of Common Stock of
the Company at the Conversion Ratio on the Maturity Date (the “Mandatory Conversion Date”).

 

(b)Not
later than ten (10) Business Days after the Mandatory Conversion Date, the Company will deliver to the Holder a certificate or
certificates containing the restrictive legends and trading restrictions required by law, if any, representing the number of shares
of Common Stock being acquired upon the mandatory conversion of this Note; provided, however that the Company shall not
be obligated to issue certificates evidencing the equity securities issuable upon conversion of this Note, until the Note is either
delivered for conversion to the Company or any transfer Holder of the Note or Common Stock, or the Holder notifies the Company
that the Note have been lost, stolen or destroyed and provides a lost instrument indemnity or bond to the Company to indemnify
the Company from any loss incurred by it in connection therewith. The Company covenants and agrees that it shall comply with Sections
3(d) through (g) with respect to any mandatory conversion and such sections are incorporated by reference herein.

 

    	4

    	 

    

 

 

Section
5.Payment of Principal and Redemption.

 

(a)In
the event of an occurrence of an Event of Default, then the outstanding principal balance of this Note shall be due and payable
in full on the Maturity Date. Prior to the Mandatory Conversion Date this Note may not be prepaid.

 

(b)Nothing
in this Section 5 shall impair the Holder’s right to convert this Note pursuant to Section 3 prior to the Mandatory Conversion
Date.

 

Section
6.Definitions. For the purposes hereof, the following terms shall have the following meanings:

 

“Business
Day” shall mean any day, except a Saturday, Sunday or other day on which commercial banks in the State of California are
authorized or required by law to close.

 

“Conversion
Ratio” means, at any time, a fraction, of which the numerator is the outstanding principal amount represented by any Note
plus accrued but unpaid interest, and of which the denominator is the Conversion Price at such time.

 

“Original
Issue Date” means the date of the first issuance of this Note regardless of the number transfers hereof.

 

Section
7.Stockholder Rights. This Note shall not entitle the Holder to any of the rights of a stockholder of the Company,
including without limitation, the right to vote, to receive dividends and other distributions, or to receive any notice of, or
to attend, meetings of stockholders or any other proceedings of the Company, unless and to the extent converted into shares of
Common Stock in accordance with the terms hereof.

 

Section
8.Lost Note. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver,
in exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen
or destroyed debenture, a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed but only upon
receipt of evidence of such loss, theft or destruction of such Note, and of the ownership hereof, and indemnity or bond, if requested,
all reasonably satisfactory to the Company.

 

Section
9.Governing Law. This Note shall be governed by and construed in accordance with the laws of the State of California,
without giving effect to conflicts of laws thereof.

 

Section
10.Notices. All notices or other communications hereunder shall be given, and shall be deemed duly given and received,
if given, in the manner set forth in Section 5(h).

 

 

    	5

    	 

    

 

Section
11.Waiver. Any waiver by the Company or the Holder a breach of any provision of this Note shall not operate as
or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The
failure of the Company or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not
be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other
term of this Note. Any waiver must be in writing.

 

Section
12. Severability. If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note
shall remain in effect, and if any provision is inapplicable to any person or circumstance, it shall nevertheless remain applicable
to all other persons and circumstances.

 

IN
WITNESS WHEREOF, the Company has caused this instrument to be duly executed by an officer thereunto duly authorized as of the
date first above indicated.

 

 

VG LIFE SCIENCES
INC.,

a Delaware
corporation

 

 

By:    /s/
Haig Keledjian                        

Name:Haig
Keledjian

Title:Chairman

 

 

 

    	6

    	 

    

 

EXHIBIT A

 

NOTICE OF CONVERSION

AT THE ELECTION OF HOLDER

 

(To be Executed by the Registered Holder
in order to Convert the Note)

 

The undersigned hereby irrevocably elects
to convert the above Note into shares of Common Stock, no par value per share (the “Common Stock”), of VG Life Sciences
Inc. (the “Company”) according to the conditions hereof, as of the date written below. If shares are to be issued in
the name of a person other than undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering
herewith such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will be charged
to the Holder for any conversion, except for such transfer taxes, if any.

 

 

	Conversion calculations:	 
	 	Date to Effect Conversion
	 	 
	 	Principal Amount of Notes to be Converted
	 	 
	 	Applicable Conversion Price
	 	 
	 	Signature
	 	 
	 	Name:
	 	 
	 	Address:

 

 

 

    	7

    	 

    

 

Schedule of Cash Proceeds from Wild
Harp Holdings, LLC 

and Received by VG Life Sciences Inc.

 

 

 

	July 9, 2014	 	$100,000.00
	 	 	 
	September 16, 2014	 	$50,000.00
	 	 	 
	 	 	$ __________
	Date: __________	 	 
	 	 	 
	 	 	$ __________
	Date: __________	 	 
	 	 	 
	 	 	$ __________
	Date: __________	 	 

 

 

 

    	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]